There have also been studies looking at the effects of PD-1/PD-L1 blockade on dendritic cells (DCs) and natural killer (NK) cells, both within and outside of the tumor microenvironment, particularly in tumor-draining lymph nodes. This evidence concerns the gene PDCD1 and neoplasm.